Pharmalogic ApS: Financial statements 2022
CVR: 42323519
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Pharmalogic ApS (CVR 42323519) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 7,396,258 and a net result of DKK 578,397. Equity in the 2022 report amounted to DKK 1,142,064. The solvency ratio was 31.5%. The company had 7 employees in the financial year.
- Gross Profit
- DKK 7,396,258
- Profit/Loss
- DKK 578,397
- Equity
- DKK 1,142,064
- Total Assets
- DKK 3,629,308
- Employees
- 7
Official annual report
Keep an eye on Pharmalogic ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Pharmalogic ApS has published its interim report for the period April 14, 2021 – December 31, 2021.
About Pharmalogic ApS
Pharmalogic ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2021. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Tanja Dybdal Beck and Allan Christian Beck. The company is owned by DYBDAL BECK INVEST ApS. According to the 2025 annual report, the company had an average of 23 employees. In 2025, the company reported a gross profit of DKK 25,106,323 and a net result of DKK 1,079,238 compared with DKK -693,511 the year before. Equity in the 2025 report amounted to DKK 1,340,263.